Androgel, Axiron, Fortesta, Testim, Delatestryl, Striant, Androderm and Testopel Lawsuits
Have you or a loved one experienced a heart attack, deep vein thrombosis, pulmonary embolism or stroke while using a testosterone medication? Litigation and lawsuits have commenced based upon recent medical studies showing a greatly increased risk of a heart attack (myocardial infarction) occurring in users of testosterone prescriptions. Our firm's senior litigation partner, Paul D. Rheingold, has represented thousands of clients and gained millions of dollars in verdicts and settlements for other prescription hormone drugs.
The New York testosterone lawyers of Giuffra, have a dedicated team of lawyers and legal staff individually handling claims. In other hormone-related drug product liability litigation, we have represented clients from many states.
Helping Clients Nationwide
The Dangers of Low-T Prescription Medication with Testosterone
We allege that the risks of Low-T testosterone drugs were not adequately communicated to users, and that the product exposes men to heightened risk of:
- Heart Attack (myocardial infarction)
- Blood clots
- Pulmonary embolism
- DVT (Deep Vein Thrombosis)
Could There Be Liability against Testosterone Drug Companies Based on Over-Promotion or Direct-to-Consumer Advertising?
Testosterone supplementation is approved by the FDA only to treat specific diseases due to having low levels of testosterone. Any prescribing or use for general alleged health benefits in persons is therefore an "off label" use. This happens, in part, due to print and media ads blanketing magazines and cable television. The great majority of prescriptions currently are for such off label uses. Even more disturbing is that a large number of users have not even had the blood test to determine if in fact they have low levels of testosterone! The FDA on January 31, 2014, issued a Safety Announcement that it was investigating cases of heart attack, stroke and death in men who had been using testosterone medication. The basis for this intervention was recent articles linking testosterone supplementation to these conditions. For example, the University of Florida mined data from an insurer, looking at the rate of heart attack within 90 days of the use of testosterone. They found that in men over 65 the risk more than doubled, compared to the control group. In men under 65, who had risk factors for a heart attack, the risk was between double and triple!
At Rheingold Giuffra Ruffo & Plotkin LLP, we have been serving the legal needs of people throughout New York and across the nation for over 30 years. We handle a wide range of complex cases involving drugs containing hormones. Our attorneys are experienced litigators with a long track record of success, winning settlements and jury awards for our clients. We are happy to answer any questions you may have, and help you explore your legal options.
Testosterone Lawsuits Transferred to Multi District Litigation
Federal lawsuits filed against manufacturers of Low-T testosterone drug manufacturers have been consolidated in the U.S. District Court for the Northern District of Illinois. Lawsuits are transferred upon the determination of the U.S. Judicial Panel on Multidistrict Litigation. Judge Matthew F. Kennelly will preside over the litigation.
This is an important step in the resolution of these claims. We have resolved hundreds of MDL cases and look forward to helping you resolve your Testosterone case.
Contact Us for a Case Evaluation
Have you or someone close to you suffered from the use of Androgel, Axiron, Fortesta, Testim, Delatestryl, Striant, Androderm or Testopel?
Please contact us today online or by telephone at (888) 260-0473 to speak with an experienced New York drug liability law firm.
Our law office is conveniently located in a brownstone in Midtown Manhattan located at 113 East 37th Street.
For more information, please visit our drugs and medical devices information center.